+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Serine/Threonine Protein Kinase A Raf - Pipeline Review, H1 2020 - Product Thumbnail Image

Serine/Threonine Protein Kinase A Raf - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 34 Pages
  • Global
From
Precision Medicine Market Report 2023-2033 - Product Thumbnail Image

Precision Medicine Market Report 2023-2033

  • Report
  • June 2023
  • 347 Pages
  • Global
From
From
Chronic Kidney Disease (CKD) Drugs Market 2024-2028 - Product Thumbnail Image

Chronic Kidney Disease (CKD) Drugs Market 2024-2028

  • Report
  • November 2023
  • 184 Pages
  • Global
From
From
From
Interferon - Global Strategic Business Report - Product Thumbnail Image

Interferon - Global Strategic Business Report

  • Report
  • May 2025
  • 78 Pages
  • Global
From
From
Viral Vector Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Viral Vector Collaboration and Licensing Deals 2016-2024

  • Report
  • November 2024
  • 250 Pages
  • Global
From
Genomic Collaboration and Licensing Deals 2018-2024 - Product Thumbnail Image

Genomic Collaboration and Licensing Deals 2018-2024

  • Report
  • November 2024
  • 350 Pages
  • Global
From
From
From
From
From
From
Loading Indicator